Editorial: Community series in neurobiological biomarkers for developing novel treatments of substance and non-substance addiction, volume II

• Yehong Fang,
• Yi Liu,
• Ling Li,
• Dara G. Ghahremani,
• Jianhua Chen,
• Kyoji Okita,
• Wenbin Guo,
• Yanhui Liao

Affiliations

Yehong Fang

Department of Psychiatry, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China

Yi Liu

Department of Psychiatry, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China

Ling Li

Department of Psychiatry, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China

Dara G. Ghahremani

Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles, CA, United States

Jianhua Chen

Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Kyoji Okita

Integrative Brain Imaging Center of National Center of Neurology and Psychiatry, Kodaira, Japan

Wenbin Guo

National Clinical Research Center for Mental Disorders, Department of Psychiatry, The Second Xiangya Hospital of Central South University, Changsha, China

Yanhui Liao

Department of Psychiatry, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China